These data suggest a possible role for eEF2K/eEF2 signalling in driving an aggressive leukemia model and demonstrate that targeting mTORC1-eEF2K signalling can inactivate eEF2 and potentially deregulate protein translation elongation. This evidence concerns the gene EEF2 and leukemia.